Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

rifamycin SV MeSH Supplementary Concept Data 2025


MeSH Supplementary
rifamycin SV
Unique ID
C023808
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C023808
Entry Term(s)
5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2-H)-dione, 21-acetate
Aemcolo
Otafa
R-75-1
Rifacin
Rifamicina Colirio
Rifamycine Chibret
Rifocina
Rifocyna
rifamycin
rifamycin SV, monosodium salt
rifamycin SV, sodium salt
Pharm Action
Antirheumatic Agents
Registry Numbers
DU69T8ZZPA
0
14897-39-3
15105-92-7
Related Numbers
14897-39-3
15105-92-7
6998-60-3
Heading Mapped to
*Rifamycins
Frequency
407
Note
RN given refers to parent cpd; structure in Merck Index, 9th ed, #8009
Source
J Int Med Res 1980;8(1):1
Date of Entry
2024/08/09
Revision Date
2023/12/18
rifamycin SV Preferred
Rifacin Narrower
rifamycin SV, sodium salt Narrower
rifamycin SV, monosodium salt Narrower
Otafa Narrower
Rifamicina Colirio Narrower
Rifocina Narrower
Rifocyna Narrower
R-75-1 Narrower
Aemcolo Related
page delivered in 0.006s